Literature DB >> 16204005

Geographic and socioeconomic variation in the treatment of prostate cancer.

Tracey L Krupski1, Lorna Kwan, Abdelmonem A Afifi, Mark S Litwin.   

Abstract

PURPOSE: Within a framework of quality assessment, primary treatment choice constitutes an indicator of quality of care. This study examines geographic and socioeconomic variation in the primary treatment of men with prostate cancer during the era of prostate-specific antigen testing.
METHODS: Using the National Cancer Institute's Surveillance, Epidemiology, and End Results public use data files, we identified men with localized/regional prostate cancer who underwent surgery, radiation therapy, or watchful waiting. We used the year 2000 US Census information to ascribe education and income levels to these men based on their county of residence and ethnicity.
RESULTS: Among the 96,769 men with localized/regional prostate cancer (during 1995 to 1999) who had sufficient information for analysis, we observed significant geographic variation nationwide in surgical, radiation, and watchful waiting treatment rates (P <.0015). Patterns noted 10 years ago, such as higher surgical rates in western regions, persisted. Ethnicity, income, and grade were all independently associated with primary treatment, or lack thereof. Blacks and low-income patients had the lowest rates of surgery and radiation. Grade was the best predictor of aggressive treatment.
CONCLUSION: Nonclinical factors, such as ethnicity and income, were associated with the use of watchful waiting rather than surgery or radiation in men with early-stage prostate cancer. These findings have implications for quality of care.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204005     DOI: 10.1200/JCO.2005.08.755

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  44 in total

1.  Minimizing disparities in surgical care: a research focus for the future.

Authors:  Joan J Ryoo; Clifford Y Ko
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

2.  Understanding regional variation in Medicare expenditures for initial episodes of prostate cancer care.

Authors:  Shi-Yi Wang; Rong Wang; James B Yu; Xiaomei Ma; Xiao Xu; Simon P Kim; Pamela R Soulos; Avantika Saraf; Cary P Gross
Journal:  Med Care       Date:  2014-08       Impact factor: 2.983

3.  Urologist Practice Structure and Spending for Prostate Cancer Care.

Authors:  Parth K Modi; Lindsey A Herrel; Samuel R Kaufman; Phyllis Yan; Tudor Borza; Ted A Skolarus; Florian R Schroeck; Brent K Hollenbeck; Vahakn B Shahinian
Journal:  Urology       Date:  2019-04-25       Impact factor: 2.649

4.  Prostate cancer. Socioeconomic status and disparities in treatment patterns.

Authors:  David I Chu; Stephen J Freedland
Journal:  Nat Rev Urol       Date:  2010-09       Impact factor: 14.432

5.  Diagnostic and treatment pathways for men with prostate cancer in Queensland: investigating spatial and demographic inequalities.

Authors:  Peter D Baade; Joanne F Aitken; Megan Ferguson; Robert A Gardiner; Suzanne K Chambers
Journal:  BMC Cancer       Date:  2010-08-23       Impact factor: 4.430

6.  Variation in quality of care among older men with localized prostate cancer.

Authors:  Ravishankar Jayadevappa; Sumedha Chhatre; Jerry C Johnson; S Bruce Malkowicz
Journal:  Cancer       Date:  2010-12-14       Impact factor: 6.860

7.  Racial variation in the quality of surgical care for prostate cancer.

Authors:  Daniel A Barocas; Darryl T Gray; Jay H Fowke; Nathaniel D Mercaldo; Jeffrey D Blume; Sam S Chang; Michael S Cookson; Joseph A Smith; David F Penson
Journal:  J Urol       Date:  2012-08-16       Impact factor: 7.450

8.  Population based time trends and socioeconomic variation in use of radiotherapy and radical surgery for prostate cancer in a UK region: continuous survey.

Authors:  Georgios Lyratzopoulos; Josephine M Barbiere; David C Greenberg; Karen A Wright; David E Neal
Journal:  BMJ       Date:  2010-04-21

9.  Evaluation of the performance of tests for spatial randomness on prostate cancer data.

Authors:  Virginia L Hinrichsen; Ann C Klassen; Changhong Song; Martin Kulldorff
Journal:  Int J Health Geogr       Date:  2009-07-03       Impact factor: 3.918

10.  Trends in non-metastatic prostate cancer management in the Northern and Yorkshire region of England, 2000-2006.

Authors:  L Fairley; M Baker; J Whiteway; W Cross; D Forman
Journal:  Br J Cancer       Date:  2009-11-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.